8-K
Current Report
Vir Biotechnology, Inc. Filed Acc 0001193125-23-294328
Exit or restructuring costs
- Item 2.05 Costs associated with exit or disposal activities
From the SEC's structured data for this filing
Loading d643902d8k.htm…